Sandy Shaw is the founder of Prime Genomics, a low cost, non-intrusive screening of breast cancer using saliva. It is the first line before mammography to increase access to early diagnosis. Sandy is joined by colleague Tom Loker.
Sandy Shaw is the founder of Prime Genomics, a low cost, non-intrusive screening of breast cancer using saliva. It is the first line before mammography to increase access to early diagnosis. Sandy is joined by colleague Tom Loker.